Company research

Brainsway Ltd. American Depositary Shares (BWAY) stock fundamentals

BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, East Asia, and internationally. It offers Deep Transcranial Magnetic Stimulation platform techno

As of 2026-10-09

Exchange
XNAS
Sector
Healthcare
Industry
Medical Devices

Read this company snapshot

Step 1 of 3

Daily valuation snapshot

Brainsway Ltd. American Depositary Shares: source evidence dated 2026-10-09.

Daily close (USD)
$11.77
Market capitalization (USD)
$921,963,073.24
Price / earnings (TTM)
121.71
Price / book
Not reported
What you should see

The source values and product destination above identify the example to inspect.

Step 2 of 3

What business is this, and what does its dated valuation mean?

Check the market day first. P/E uses trailing earnings; book value and market capitalization answer different questions.

Daily valuation dataset and column definitions
What you should see

Open the company research view or ask Aurora to reconcile reporting periods, earnings, debt and the figures behind the valuation.

Step 3 of 3

Research BWAY in the app

Open the company research view or ask Aurora to reconcile reporting periods, earnings, debt and the figures behind the valuation.

Research BWAY in the app
What you should see

Keep reporting dates and units beside the answer, and inspect its original citations.

Company overview

BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, East Asia, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company serves doctors, hospitals, and medical centers in the field of psychiatry. The company was founded in 2003 and is headquartered in Jerusalem, Israel.

Daily valuation snapshot

See the complete daily valuation snapshot

These values come from the daily market snapshot dated 2026-10-09. TTM means trailing twelve months. Use the market date when comparing BWAY with another company.

Scroll sideways to compare all columns. Select a heading to sort.

Daily close (USD)$11.77
Market capitalization (USD)$921,963,073.24
Price / earnings (TTM)121.71
Price / bookNot reported

Read BWAY's valuation metrics

  1. Company size

    Brainsway Ltd. American Depositary Shares's recorded market capitalization is $921,963,073.24. It measures the market value of the company's equity, rather than its revenue or cash balance.

  2. Price relative to earnings

    BWAY's recorded P/E is 121.71: about $121.71 of share price for each $1 of trailing annual earnings per share. Compare that multiple with earnings growth and companies in the same business.

  3. Price relative to book equity

    Price-to-book compares market equity value with recorded book equity. Intangible assets, profitability and the company's business affect how useful the comparison is.

Research Brainsway Ltd. American Depositary Shares with Aurora

Use the snapshot above to ask a specific question about BWAY. Ask for the report period and the figures behind the explanation, then compare the answer with the company's business description.

Continue the research

Follow BWAY's ownership disclosures to see who filed a transaction or position and when it became public. To turn a research idea into a strategy, define an entry rule and test its dated observations.

Aurora · AI research assistant

Try this in Aurora

Edit the request, then open it in Aurora. You choose when to send it.